Sample test method, microfluidic device, and test device

US2018180536A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018180536-A1
Application numberUS-201815891632-A
CountryUS
Kind codeA1
Filing dateFeb 8, 2018
Priority dateAug 12, 2014
Publication dateJun 28, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A sample test method, microfluidic device, and test device efficiently and accurately compensates for interference of an interfering substance present in a sample using optical measurement without addition of a separate reagent for detecting the interfering substance. The sample test method includes: measuring an optical characteristic value of a target substance present in a sample; measuring an optical characteristic value of an interfering substance present in the sample; and determining a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance.

First claim

Opening claim text (preview).

What is claimed is: 1 . A sample test method comprising: measuring an optical characteristic value of a target substance present in a sample; measuring an optical characteristic value of an interfering substance present in the sample; and determining a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance, wherein the determining the concentration of the target substance for which interference of the interfering substance is compensated for comprises: determining the concentration of the target substance based on the optical characteristic value of the target substance, and determining the concentration of the interfering substance based on the optical characteristic value of the interfering substance, and compensating the concentration of the target substance using the concentration of the interfering substance. 2 . The sample test method of claim 1 , wherein the compensating the optical characteristic value of the target substance comprises: applying a fluctuation coefficient to the concentration of the interfering substance to obtain an application result, and then subtracting or adding the application result from or to the concentration of the target substance. 3 . The sample test method of claim 1 , wherein the measuring the optical characteristic value of the target substance comprises: measuring optical characteristic values of the target substance at a main wavelength and a sub-wavelength; and subtracting the optical characteristic value at the sub-wavelength from the optical characteristic value at the main wavelength. 4 . The sample test method of claim 1 , wherein the sample includes blood, and wherein the target substance includes gamma-glutamyl transferase (GGT). 5 . The sample test method of claim 1 , wherein the interfering substance includes bilirubin. 6 . The sample test method of claim 1 , wherein the measuring the optical characteristic value of the interfering substance is done without presence of a reagent for reacting with the interfering substance. 7 . The sample test method according to claim 1 , wherein the optical characteristic value is representative of concentration amount of at least one of the target substance and the interfering substance, and the sample test method is performed using one or more processors. 8 . A test device comprising: a measurer configured to measure an optical characteristic value of a target substance present in a sample and an optical characteristic value of an interfering substance present in the sample; and a data processor configured to determine a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance, wherein the data processor is configured to determine the concentration of the target substance based on the optical characteristic value of the target substance, and determine the concentration of the interfering substance based on the optical characteristic value of the interfering substance, and compensate the concentration of the target substance using the concentration of the interfering substance. 9 . The test device of claim 8 , wherein the data processor is configured to apply a fluctuation coefficient to the concentration of the interfering substance to obtain an application result, and then subtract or add the application result from or to the concentration of the target substance. 10 . The test device of claim 8 , wherein the measurer is configured to the measure optical characteristic value of the target substance at a main wavelength and a sub-wavelength, and wherein the data processor is configured to subtract the optical characteristic value measured at the sub-wavelength from the optical characteristic value measured at the main wavelength. 11 . The test device of claim 8 , wherein the sample includes blood, and wherein the target substance includes gamma-glutamyl transferase (GGT). 12 . The test device of claim 8 , wherein the measurer is configured to the measure optical characteristic value of the sample at a plurality of wavelengths, and wherein the data processor is configured to determine a final optical characteristic value from the measured optical characteristic values of the sample, wherein the final optical characteristic value is an optical characteristic value for the interfering substance. 13 . The test device of claim 11 , wherein the interfering substance includes bilirubin.

Assignees

Inventors

Classifications

  • Flow-through cuvettes (G01N21/09 takes precedence; handling fluid samples G01N1/10) · CPC title

  • with definite EC number (2.3.2.-) · CPC title

  • G01N21/31Primary

    Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry {(G01N21/72 takes precedence)} · CPC title

  • Determining multicomponents by multiwavelength light · CPC title

  • Bile pigment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018180536A1 cover?
A sample test method, microfluidic device, and test device efficiently and accurately compensates for interference of an interfering substance present in a sample using optical measurement without addition of a separate reagent for detecting the interfering substance. The sample test method includes: measuring an optical characteristic value of a target substance present in a sample; measuring …
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification G01N21/31. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Jun 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).